Evaluation of the SEIMC score as a death predictor of SARS-CoV-2 pneumonia in vaccinated patients: a validation cohort
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
This is a single-centre prospective cohort study to validate the Spanish Society of Infectious Diseases and Microbiology (SEIMC) score for predicting 28-days mortality in vaccinated patients with SARS-CoV-2 pneumonia.
Methods
We included 127 adult patients with confirmed SARS-CoV-2 infection by polymerase chain reaction (PCR) admitted to the hospital ward. Among them, 92 were unvaccinated, 17 one-dose vaccinated and 18 two-doses. The SEIMC score was calculated at admission, and we analysed its correlation with 28-days mortality.
Results
We found significant differences between the number of vaccinations according to the SEIMC score classification. The SEIMC score and 28-days mortality were significantly correlated in the whole cohort (p=0.001), in unvaccinated patients (p=0.001) and in those with some vaccine doses (p=0.003) or two-doses (p = 0.005), but not in one-dose vaccinated patients (p=0.235).
Conclusion
The SEIMC score remains a useful scale for predicting 28-day mortality in vaccinated patients.
